Ligand Pharmaceuticals Incorporated (LGND) Social Stream



Ligand Pharmaceuticals Incorporated (LGND): $78.87

1.05 (-1.31%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add LGND to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#129 of 363

in industry

Featured Post From StockTwits About LGND

$LGND NEW DELHI // Updated: August 11, 2021, 13:33 IST
The government has a reserve stock of nearly 50 lakh vials of Remdesivir and plans production of Tocilizumab as part of its expansive preparations for a possible third wave of Covid-19, top government sources have told News18.

A top source said the government presently has 50 lakh vials of Remdesivir in stock and has plans for domestic production of Tocilizumab as well in preparation for a possible third wave. The 50 lakh vials of Remdesivir were kept as a reserve for immediate release to states during emergencies. News18 has learnt that the seven licensed manufacturers of the drug in India now have a monthly capacity of nearly 1.25 crore vials per month and they have produced a total of nearly 3 crore vials so far. The export of Remdesivir could also start soon.
BioMania33, published August 12, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!